Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Levorphanol Tartrate Anhydrous
2. Levorphan Tartrate
3. Levorphanol Bitartrate
4. Wcb1i20f1k
5. 125-72-4
6. D-(-)-levorphanol Tartrate
7. Morphinan-3-ol, 17-methyl-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) (salt)
8. L-3-hydroxy-n-methylmorphinan Tartrate
9. Ro 1-5431/7
10. Levorphanol Hydrogen Tartrate
11. Nih 4590
12. Einecs 204-753-8
13. Nsc 91012
14. Unii-wcb1i20f1k
15. Nsc-91012
16. Levorphanol L-tartrate
17. Morphinan-3-ol, 17-methyl-, Tartrate (1:1) (salt), (-)-
18. Morphinan-6-ol, N-methyl-, Tartrate (1:1) (salt), Stereoisomer
19. 2h-10,4a-iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, Tartrate
20. Schembl4336924
21. Dtxsid30924987
22. Pdsp2_001546
23. Levorphanol Tartrate [who-dd]
24. Morphinan-3-ol, 17-methyl-, (2r,3r)-2,3-dihydroxybutanedioate (1:1)
25. Q27292556
26. 17-methylmorphinan-3-ol, Tartrate (1:1) (salt)
27. 17-methylmorphinan-3-ol (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)
Molecular Weight | 407.5 g/mol |
---|---|
Molecular Formula | C21H29NO7 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 3 |
Exact Mass | 407.19440226 g/mol |
Monoisotopic Mass | 407.19440226 g/mol |
Topological Polar Surface Area | 139 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 491 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Levorphanol tartrate |
Drug Label | Levo-Dromoran (levorphanol tartrate) is a potent opioid analgesic with empirical formula C17H23NOC4H6O62H2O and molecular weight 443.5. Each mg of levorphanol tartrate is equivalent to 0.58 mg levorphanol base. Chemically levorphanol is levo-3-... |
Active Ingredient | Levorphanol tartrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg |
Market Status | Prescription |
Company | Roxane |
2 of 2 | |
---|---|
Drug Name | Levorphanol tartrate |
Drug Label | Levo-Dromoran (levorphanol tartrate) is a potent opioid analgesic with empirical formula C17H23NOC4H6O62H2O and molecular weight 443.5. Each mg of levorphanol tartrate is equivalent to 0.58 mg levorphanol base. Chemically levorphanol is levo-3-... |
Active Ingredient | Levorphanol tartrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg |
Market Status | Prescription |
Company | Roxane |
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-03-07
Pay. Date : 2019-01-28
DMF Number : 33224
Submission : 2018-12-31
Status : Active
Type : II
NDC Package Code : 58159-061
Start Marketing Date : 2024-12-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-08-16
Pay. Date : 2021-06-10
DMF Number : 35977
Submission : 2021-05-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-05-17
Pay. Date : 2023-04-03
DMF Number : 34304
Submission : 2020-01-17
Status : Active
Type : II
NDC Package Code : 50683-0514
Start Marketing Date : 2019-12-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-11-21
Pay. Date : 2017-09-08
DMF Number : 18823
Submission : 2005-09-29
Status : Active
Type : II
NDC Package Code : 0406-0545
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20747
Submission : 2007-08-02
Status : Active
Type : II
NDC Package Code : 0406-0545
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7625
Submission : 1988-08-09
Status : Inactive
Type : II
NDC Package Code : 0406-0545
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9968
Submission : 1992-11-13
Status : Inactive
Type : II
NDC Package Code : 0406-0545
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3726
Submission : 1980-02-15
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVO-DROMORAN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date : 1991-12-19
Application Number : 8719
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVORPHANOL TARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2000-03-31
Application Number : 74278
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVORPHANOL TARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2018-06-18
Application Number : 74278
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVORPHANOL TARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2018-06-18
Application Number : 74278
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVORPHANOL TARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2019-12-13
Application Number : 212024
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVORPHANOL TARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2020-07-01
Application Number : 213479
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVORPHANOL TARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2021-01-12
Application Number : 213479
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVORPHANOL TARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2021-07-20
Application Number : 213479
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVORPHANOL TARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2021-06-17
Application Number : 213906
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVORPHANOL TARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2023-04-25
Application Number : 213906
Regulatory Info : RX
Registration Country : USA
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Levorphanol Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levorphanol Tartrate, including repackagers and relabelers. The FDA regulates Levorphanol Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levorphanol Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levorphanol Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levorphanol Tartrate supplier is an individual or a company that provides Levorphanol Tartrate active pharmaceutical ingredient (API) or Levorphanol Tartrate finished formulations upon request. The Levorphanol Tartrate suppliers may include Levorphanol Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Levorphanol Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levorphanol Tartrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Levorphanol Tartrate active pharmaceutical ingredient (API) in detail. Different forms of Levorphanol Tartrate DMFs exist exist since differing nations have different regulations, such as Levorphanol Tartrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levorphanol Tartrate DMF submitted to regulatory agencies in the US is known as a USDMF. Levorphanol Tartrate USDMF includes data on Levorphanol Tartrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levorphanol Tartrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levorphanol Tartrate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levorphanol Tartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levorphanol Tartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levorphanol Tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levorphanol Tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levorphanol Tartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levorphanol Tartrate suppliers with NDC on PharmaCompass.
Levorphanol Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levorphanol Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levorphanol Tartrate GMP manufacturer or Levorphanol Tartrate GMP API supplier for your needs.
A Levorphanol Tartrate CoA (Certificate of Analysis) is a formal document that attests to Levorphanol Tartrate's compliance with Levorphanol Tartrate specifications and serves as a tool for batch-level quality control.
Levorphanol Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Levorphanol Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levorphanol Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Levorphanol Tartrate EP), Levorphanol Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levorphanol Tartrate USP).
LOOKING FOR A SUPPLIER?